Hello, we are GCCL (Global Clinical Central Lab), a specialized clinical trial sample analysis organization.
From May 31 to June 2, 2025, we will participate in the world's largest oncology conference,
ASCO 2025 (American Society of Clinical Oncology), at the KoNECT Korea Pavilion (Booth #33143)
held at McCormick Place in Chicago, USA, to build networks with global sponsors and CROs.
Visit GCCL at ASCO 2025
📍 Booth #33143 (KoNECT Pavilion)
📅 Exhibition Dates: May 31 (Sat) – June 2 (Mon)
✉️ Meeting Inquiries:
GCCL@gccorp.com
ASCO brings together over 40,000 oncology professionals from around the world
including global pharmaceutical companies, biotechs, CROs, research institutions, and government agencies
to share the latest strategies and clinical data and explore new collaboration opportunities.
Through this participation, GCCL aims to expand its global client outreach
and solidify its position as the leading central lab in the Asia-Pacific region.
GCCL CEO, KwanGoo Cho, and Global Manager, Harry Hong, will attend the event in person,
engaging in networking and partnering meetings with global stakeholders,
while gaining insights into the latest industry trends and opportunities.
🌐 Why Visit GCCL at ASCO?
✅ CAP accreditation and GCLP-compliant global quality system
✅ State-of-the-art labs equipped with ddPCR, LIMS, and more
✅ Extensive experience in oncology-focused analysis and global clinical trial projects
We hope ASCO 2025 will offer you a glimpse into the future of oncology innovations and global collaboration.
GCCL looks forward to meeting you at ASCO 2025 as your trusted global partner in end-to-end bioanalytical services for drug development.
We are committed to continuing as your trusted partner in clinical research.
Click the banner below to learn more about GCCL!
> About GCCL > Newsroom > Company News